The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Open accessAbstract
Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to mitomycin C and ionizing radiation. Although six FA genes (for subtypes A, C, D2, E, F, and G) have been cloned, their relationship to DNA repair remains unknown. In the current study, we show that a nuclear complex containing the FANCA, FANCC, FANCF, and FANCG proteins is required for the activation of the FANCD2 protein to a monoubiquitinated isoform. In normal (non-FA) cells, FANCD2 is monoubiquitinated in response to DNA damage and is targeted to nuclear foci (dots). Activated FANCD2 protein colocalizes with the breast cancer susceptibility protein, BRCA1, in ionizing radiation-induced foci and in synaptonemal complexes of meiotic chromosomes. The FANCD2 protein, therefore, provides the missing link between the FA protein complex and the cellular BRCA1 repair machinery. Disruption of this pathway results in the cellular and clinical phenotype common to all FA subtypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since BRCA1 interacts with FancD2 and mediates FancD2 foci formation after treatment with MMC (Bunting et al., 2012; Garcia-Higuera et al., 2001; Vandenberg et al., 2003)”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Garcia-Higuera et al., 2001
Experimental — accuracy not yet measuredIn the citing paper
“In addition, DNA damage induces the accumulation of BRCA-FA proteins in nuclear foci [33].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 1,151
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
Huibregtse, J. M., Scheffner, M., Beaudenon, S. L., & Howley, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2563 · Cited by 1,011
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 919
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Cited by
Sorted by citations
Items 601–700 of 1,000
A novel cell‐free screen identifies a potent inhibitor of the Fanconi anemia pathway
Landais, I., Sobeck, A., Stone, S., LaChapelle, A., & Hoatlin, M. E. (2008) · International Journal of Cancer · doi:10.1002/ijc.24039 · Cited by 37
Meyer, S., Fergusson, W. D., Whetton, A. D., Moreira-Leite, F. F., Pepper, S. D. V., Miller, C. J., Saunders, E., White, D. J., Will, A., Eden, T. O. B., et al. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20417 · Cited by 37
Mechanistic link between DNA damage sensing, repairing and signaling factors and immune signaling
Mukherjee, S., Abdisalaam, S., Bhattacharya, S., Kalayarasan, S., Sinha, D., & Asaithamby, A. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.11.004 · Cited by 39
The Fanconi anemia gene network is conserved from zebrafish to human
Titus, T. A., Selvig, D., Qin, B., WILSON, C. A., Starks, A. M., Roe, B. A., & Postlethwait, J. H. (2006) · Gene · doi:10.1016/j.gene.2005.11.038 · Cited by 40
The Fanconi Anemia Signalosome Anchor
Niedernhofer, L. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.002 · Cited by 37
de Sousa, M. M. L., Zub, K. A., Aas, P. A., Hanssen‐Bauer, A., Demirović, A., Sarno, A., Tian, E., Liabakk, N., & Slupphaug, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055493 · Cited by 37
C. elegans: A model of Fanconi anemia and ICL repair
Youds, J. L., Barber, L. J., & Boulton, S. J. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.007 · Cited by 37
Dai, M., Chevallier, N., Stone, S., Heinrich, M. C., McConnell, M. J., Reuter, T., Broxmeyer, H. E., Licht, J. D., Lu, L., & Hoatlin, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201834200 · Cited by 38
Parplys, A. C., Seelbach, J. I., Becker, S., Behr, M., Wrona, A., Jend, C., Mansour, W. Y., Joosse, S. A., Stuerzbecher, H.-W., Pospiech, H., et al. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1055996 · Cited by 36
Cracking the Monoubiquitin Code of Genetic Diseases
Sewduth, R. N., Baietti, M. F., & Sablina, A. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093036 · Cited by 36
Helq acts in parallel to Fancc to suppress replication-associated genome instability
Luebben, S. W., Kawabata, T., Akre, M. K., Lee, W. L., Johnson, C. S., O’Sullivan, M. G., & Shima, N. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt676 · Cited by 36
Sourisseau, T., Hélissey, C., Lefèbvre, C., Ponsonnailles, F., Malka-Mahieu, H., Olaussen, K. A., André, F., Vagner, S., & Soria, J. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1120918 · Cited by 38
CtIP Is Required to Initiate Replication-Dependent Interstrand Crosslink Repair
Duquette, M. L., Zhu, Q., Taylor, E. R., Tsay, A. J., Shi, L. Z., Berns, M. W., & McGowan, C. H. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003050 · Cited by 39
An, J. Y., Kim, E., Zakrzewska, A., Yoo, Y. D., Jang, J. M., Han, D. H., Lee, M. J., Seo, J. W., Lee, Y. J., Kim, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037414 · Cited by 38
Cheung, R. S., Castellà, M., Abeyta, A., Gafken, P. R., Tucker, N., & Taniguchi, T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.081 · Cited by 35
Self-citationSelective Killing of Cancer Cells by Nonplanar Aromatic Hydrocarbon‐Induced DNA Damage
Zhou, Y., Gan, F., Zhang, Y., He, X., Shen, C., Qiu, H., & Liu, P. (2019) · Advanced Science · doi:10.1002/advs.201901341 · Cited by 35
Rego, M. A., Harney, J. A., Mauro, M., Shen, M., & Howlett, N. G. (2011) · Oncogene · doi:10.1038/onc.2011.237 · Cited by 37
Wu, Y., & Brosh, R. M. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167159 · Cited by 37
DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer
Alexander, B. M., Sprott, K. M., Farrow, D. A., Wang, X., D’Andrea, A. D., Schnitt, S. J., Collins, L. C., Weaver, D. T., & Garber, J. E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0292 · Cited by 35
Self-citationCell resistance to the Cytolethal Distending Toxin involves an association of DNA repair mechanisms
Bezine, E., Malaisé, Y., Loeuillet, A., Chevalier, M., Boutet-Robinet, E. A., Salles, B., Mirey, G., & Vignard, J. (2016) · Scientific Reports · doi:10.1038/srep36022 · Cited by 35
Savino, M., Borriello, A., D’Apolito, M., Criscuolo, M., Vecchio, M. D., Bianco, A. M., Perna, M. D., Calzone, R., Nobili, B., Zatterale, A., et al. (2003) · Human Mutation · doi:10.1002/humu.9180 · Cited by 35
The Fanconi anemia group C gene product
Fagerlie, S. R., Lensch, M. W., Pang, Q., & Bagby, G. C. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00755-x · Cited by 36
The Fanconi anemia ID2 complex: Dueling saxes at the crossroads
Boisvert, R. A., & Howlett, N. G. (2014) · Cell Cycle · doi:10.4161/15384101.2014.956475 · Cited by 38
Rescue of replication failure by Fanconi anaemia proteins
Constantinou, A. (2011) · Chromosoma · doi:10.1007/s00412-011-0349-2 · Cited by 40
A requirement of FancL and FancD2 monoubiquitination in DNA repair
Seki, S., Ohzeki, M., Uchida, A., Hirano, S., Matsushita, N., Kitao, H., Oda, T., Yamashita, T., Kashihara, N., Tsubahara, A., et al. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01054.x · Cited by 35
Fanconi Anemia: Causes and Consequences of Genetic Instability
Kalb, R., Neveling, K., Nanda, I., Schindler, D., & Hoehn, H. (2006) · KARGER eBooks · doi:10.1159/000092510 · Cited by 35
A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing
Solomon, P. J., Margaret, P., Rajendran, R., Ramalingam, R., Menezes, G. A., Shirley, A. S., Lee, S. J., Seong, M., Park, S. S., Seol, D., et al. (2015) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-015-0142-6 · Cited by 34
BRCA1—A good predictive marker of drug sensitivity in breast cancer treatment?
Mullan, P. B., Gorski, J. J., & Harkin, D. P. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.07.001 · Cited by 34
Fanconi Anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments
Kachnic, L. A., Li, L., Fournier, L., & Willers, H. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.11.009 · Cited by 34
Hölzel, M., van Diest, P. J., Bier, P., Wallisch, M., Hoatlin, M. E., Joenje, H., & de Winter, J. P. (2003) · The Journal of Pathology · doi:10.1002/path.1450 · Cited by 37
Grillari, J., Grillari‐Voglauer, R., & Jansen‐Dürr, P. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7002-2_13 · Cited by 36
Fagerholm, R., Sprott, K. M., Heikkinen, T., Bártková, J., Heikkilä, P., Aittomäki, K., Bártek, J., Weaver, D. T., BLOMQVIST, C. P., & Nevanlinna, H. A. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt290 · Cited by 37
The Fanconi anemia/BRCA gene network in zebrafish: Embryonic expression and comparative genomics
Titus, T. A., Yan, Y., WILSON, C. A., Starks, A. M., Frohnmayer, J. D., Bremiller, R., Cañestro, C., Rodríguez‐Marí, A., He, X., & Postlethwait, J. H. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.017 · Cited by 35
Current Knowledge on the Pathophysiology of Fanconi Anemia: From Genes to Phenotypes
Yamashita, T., & Nakahata, T. (2001) · International Journal of Hematology · doi:10.1007/bf02982547 · Cited by 34
Ferrer, M., Rodríguez, J. A., Spierings, E. A., de Winter, J. P., Giaccone, G., & Kruyt, F. A. E. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi138 · Cited by 34
The Two Faces of BRCA2, a FANCtastic Discovery
Stewart, G. S., & Elledge, S. J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00580-4 · Cited by 34
Auerbach, A. D., Greenbaum, J., Pujara, K., Batish, S. D., Bitencourt, M. A., Kokemohr, I., Schneider, H., Lobitzc, S., Pasqüini, R., Giampietro, P. F., et al. (2003) · Human Mutation · doi:10.1002/humu.10166 · Cited by 34
Rulten, S. L., Hodder, E., Ripley, T. L., Stephens, D. N., & Mayne, L. V. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00673.x · Cited by 36
Macerelli, M., Ganzinelli, M., Gouédard, C., Broggini, M., Garassino, M. C., Linardou, H., Damia, G. L. M., & Wiesmüller, L. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.05.004 · Cited by 33
Lei, L. C., Yu, V. Z., Ko, J. M. Y., Ning, L., & Lung, M. L. (2020) · Cancers · doi:10.3390/cancers12092545 · Cited by 33
Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice
Bachelier, R., Xu, X., Wang, X., Li, W., Naramura, M., Gu, H., & Deng, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206208 · Cited by 33
Newell, A. E. H., Akkari, Y. M. N., Torimaru, Y., Rosenthal, A. S., Reifsteck, C. A., Cox, B., Grompe, M., & Olson, S. B. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.01.011 · Cited by 34
Self-citationVanni, V. S., Campo, G., Cioffi, R., Papaleo, E., Salonia, A., Viganò, P., Lambertini, M., Candiani, M., Meirow, D., & Orvieto, R. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab045 · Cited by 33
The Fanconi anemia pathway in replication stress and DNA crosslink repair
Jones, M. V., & Huang, T. T. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1051-0 · Cited by 33
Small-Molecule Inhibition of UBE2T/FANCL-Mediated Ubiquitylation in the Fanconi Anemia Pathway
Cornwell, M., Thomson, G., Coates, J., Belotserkovskaya, R., Waddell, I. D., Jackson, S. P., & Galanty, Y. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00570 · Cited by 32
The DNA-damage kinase ATR activates the FANCD2-FANCI clamp by priming it for ubiquitination
Sijacki, T., Alcón, P., Chen, Z. A., McLaughlin, S. H., Shakeel, S., Rappsilber, J., & Passmore, L. A. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00820-9 · Cited by 32
Myeloid lineage‐selective growth of revertant cells in Fanconi anaemia
Hamanoue, S., Yagasaki, H., Tsuruta, T., Oda, T., Yabe, H., Yabe, M., & Yamashita, T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05916.x · Cited by 32
Regulation of the Fanconi anemia pathway by a CUE ubiquitin-binding domain in the FANCD2 protein
Rego, M. A., Kolling, F. W., Vuono, E. A., Mauro, M., & Howlett, N. G. (2012) · Blood · doi:10.1182/blood-2012-02-410472 · Cited by 32
Yoshida, Y., Tsunoda, T., Doi, K., Fujimoto, T., Tanaka, Y., Ota, T., Ogawa, M., Matsuzaki, H., Kuroki, M., Iwasaki, A., et al. (2012) · PubMed · Cited by 32
Gingerich, M. A., Smith, J. D., Michmerhuizen, N. L., Ludwig, M., Devenport, S. N., Matovina, C. N., Brenner, J. C., & Chinn, S. B. (2018) · Head & Neck · doi:10.1002/hed.25057 · Cited by 33
Ferrer, M., de Winter, J. P., Mastenbroek, D. C. J., Curiel, D. T., Gerritsen, W. R., Giaccone, G., & Kruyt, F. A. E. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700734 · Cited by 32
Deficient Regulation of DNA Double-strand Break Repair in Fanconi Anemia Fibroblasts
Donahue, S. L., Lundberg, R., Saplis, R., & Campbell, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213251200 · Cited by 32
Inherited bone marrow failure syndromes in 2012
Sakaguchi, H., Nakanishi, K., & Kojima, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1249-9 · Cited by 32
Constitutive role of the Fanconi anemia D2 gene in the replication stress response
Tian, Y., Shen, X. H., Wang, R., Klages-Mundt, N. L., Lynn, E. J., Martin, S. K., Yin, Y., Gao, M., Chen, J., Schlacher, K., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.814780 · Cited by 31
PARP inhibition and synthetic lethality in ovarian cancer
Eskander, R. N., & Tewari, K. S. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.930662 · Cited by 31
Wang, G., Liu, Y., Cheng, X., & Zhou, G. (2015) · Cancer Science · doi:10.1111/cas.12679 · Cited by 31
Mitotic DNA Synthesis Is Differentially Regulated between Cancer and Noncancerous Cells
Graber-Feesl, C. L., Pederson, K. D., Aney, K. J., & Shima, N. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0057 · Cited by 34
The Fanconi Family Adds a Fraternal Twin
Grompe, M., & van de Vrugt, H. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.008 · Cited by 31
Self-citationKarttunen, H., Savas, J. N., McKinney, C. C., Chen, Y.-H., Yates, J. R., Hukkanen, V., Huang, T. T., & Mohr, I. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.020 · Cited by 30
Specificity for deubiquitination of monoubiquitinated FANCD2 is driven by the N-terminus of USP1
Arkinson, C., Chaugule, V. K., Toth, R. L., & Walden, H. (2018) · Life Science Alliance · doi:10.26508/lsa.201800162 · Cited by 30
Yuan, F., Qian, L., Zhao, X., Liu, J. Y., Song, L., D’Urso, G., Jain, C., & Zhang, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315366 · Cited by 30
FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses
Zhang, F., Fan, Q., Ren, K., Auerbach, A. D., & Andreassen, P. R. (2010) · Chromosoma · doi:10.1007/s00412-010-0285-6 · Cited by 31
Pérez‐Alea, M., Vivancos, A. P., Caratù, G., Matito, J., Fábrega, B. F., Hernández‐Losa, J., Cortés, J., Muñoz‐Couselo, E., García‐Patos, V., & Recio, J. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8578 · Cited by 30
Defects in homologous recombination repair behind the human diseases: FA and HBOC
Katsuki, Y., & Takata, M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0221 · Cited by 32
Shao, X., Joergensen, A. M., Howlett, N. G., Lisby, M., & Oestergaard, V. H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa268 · Cited by 36
A new nuclease member of the FAN club
Huang, M., & D'Andrea, A. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0810-926 · Cited by 29
Self-citationSi, Y. C., Pulliam, A. C., Linka, Y., Ciccone, S. L. M., Leurs, C., Yuan, J., Eckermann, O., Früehauf, S., Mooney, S. D., Hanenberg, H., et al. (2008) · Blood · doi:10.1182/blood-2007-07-102947 · Cited by 29
Luebben, S. W., Kawabata, T., Johnson, C. S., O’Sullivan, M. G., & Shima, N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku170 · Cited by 29
Miles, J. A., Frost, M. G., Carroll, E., Rowe, M. L., Howard, M. J., Sidhu, A., Chaugule, V. K., Alpi, A. F., & Walden, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.675835 · Cited by 29
Bone Marrow Transplantation for Inherited Bone Marrow Failure Syndromes
Mehta, P. A., Locatelli, F., Starý, J., & Smith, F. O. (2010) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.01.002 · Cited by 29
Khanal, S., & Galloway, D. A. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007442 · Cited by 29
Ge, C., Vilfranc, C. L., Che, L., PANDITA, R. K., Hambarde, S., Andreassen, P. R., Niu, L., Olowokure, O. O., Shah, S. A., Waltz, S. E., et al. (2019) · Hepatology · doi:10.1002/hep.30529 · Cited by 29
Fagerlie, S. R., Koretsky, T., Torok‐Storb, B., & Bagby, G. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3863 · Cited by 30
Telomere dynamics in Fancg-deficient mouse and human cells
Franco, S., van de Vrugt, H. J., Fernández, P., Aracil, M., Arwert, F., & Blasco, M. A. (2004) · Blood · doi:10.1182/blood-2003-10-3626 · Cited by 30
Zhou, C., Huang, P., & Liu, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.197 · Cited by 29
Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instability
Kontou, M., Adelfalk, C., Ramírez, M. H., Ruppitsch, W., Hirsch‐Kauffmann, M., & Schweiger, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205299 · Cited by 29
The Fanconi anemia pathway promotes DNA glycosylase‐dependent excision of interstrand DNA crosslinks
Macé‐Aimé, G., Couvé, S., Khassenov, B., Rosselli, F., & Saparbaev, M. K. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20548 · Cited by 28
Tripathi, K. K., Mani, C., Clark, D. W., & Palle, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7247 · Cited by 31
Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy
Jo, U., & Kim, H. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0175 · Cited by 29
Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
Moes-Sosnowska, J., Rzepecka, I. K., Chodzynska, J., Dansonka‐Mieszkowska, A., Szafron, L. M., Balabas, A., Lotocka, R., Sobiczewski, P., & Kupryjańczyk, J. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1579955 · Cited by 29
McKinzey, D. R., Gomathinayagam, S., Griffin, W. C., Klinzing, K. N., Jeffries, E. P., Rajkovic, A., & Trakselis, M. A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100355 · Cited by 28
UBE2W Interacts with FANCL and Regulates the Monoubiquitination of Fanconi Anemia Protein FANCD2
Zhang, Y., Zhou, X., Zhao, L., Li, C., Zhu, H.-Q., Xu, L., Shan, L., Liao, X., Guo, Z., & Huang, P. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0015-9 · Cited by 28
Fanconi Anemia and Ubiquitination
Zhang, Y., Zhou, X., & Huang, P. (2007) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(07)60065-4 · Cited by 29
Meyer, S., Fergusson, W. D., Oostra, A. B., Medhurst, A. L., Waisfisz, Q., de Winter, J. P., Chen, F., Carr, T. F., Clayton‐Smith, J., Clancy, T., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20153 · Cited by 28
The Fanconi anemia pathway and the DNA interstrand cross-links repair
Rosselli, F. (2003) · Biochimie · doi:10.1016/j.biochi.2003.11.002 · Cited by 28
Human Mus81 and FANCB independently contribute to repair of DNA damage during replication
Nomura, Y., Adachi, N., & Koyama, H. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01124.x · Cited by 28
Wong, J. C. Y., & Buchwald, M. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02262-6 · Cited by 29
ZNF365 Promotes Stability of Fragile Sites and Telomeres
Zhang, Y., Shin, S. J., Liu, D., Ivanova, E. V., Foerster, F., Ying, H., Zheng, H., Xiao, Y., Chen, Z., Protopopov, A. I., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0536 · Cited by 28
Verhagen, C. V. M., Vossen, D. M., Borgmann, K., Hageman, F., Grenman, R. A., Verwijs-Janssen, M., Mout, L., Kluin, R. J. C., Nieuwland, M., Severson, T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24797 · Cited by 29
HSF2BP negatively regulates homologous recombination in DNA interstrand crosslink repair
Sato, K., Brandsma, I., van Rossum-Fikkert, S. E., Verkaik, N. S., Oostra, A. B., Dorsman, J. C., van Gent, D. C., Knipscheer, P., Kanaar, R., & Zelensky, A. N. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1219 · Cited by 29
Valeri, A., Alonso-Ferrero, M. E., Rı́o, P., Pujol, R. M., Casado, J. A., Perez, L. N., Jacome, A., Agirre, X., Calasanz, M. J., Hanenberg, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015525 · Cited by 27
Allosteric mechanism for site-specific ubiquitination of FANCD2
Chaugule, V. K., Arkinson, C., Rennie, M. L., Kämäräinen, O., Toth, R. L., & Walden, H. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0426-z · Cited by 27
Hays, L. E., Zodrow, D., Yates, J. E., Deffebach, M. E., Jacoby, D. B., Olson, S. B., Pankow, J. F., & Bagby, G. C. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604362 · Cited by 27
Fujinaka, Y., Matsuoka, K., Iimori, M., Tuul, M., Sakasai, R., Yoshinaga, K., Saeki, H., Morita, M., Kakeji, Y., Gillespie, D. A., et al. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.11.005 · Cited by 27
The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC
Léveillé, F., Ferrer, M., Medhurst, A. L., Laghmani, E. H., Rooimans, M. A., Bier, P., Steltenpool, J., Titus, T. A., Postlethwait, J. H., Hoatlin, M. E., et al. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.01.005 · Cited by 28
Phosphorylation of the Menin Tumor Suppressor Protein on Serine 543 and Serine 583
MacConaill, L. E., Hughes, C. M., Rozenblatt–Rosen, O., Nannepaga, S., & Meyerson, M. M. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0123 · Cited by 27
Fanconi anemia protein complex is a novel target of the IKK signalsome
Otsuki, T., Young, D. B., Sasaki, D. T., Pando, M. P., Li, J., Manning, A. M., Hoekstra, M. F., Hoatlin, M. E., Mercurio, F., & Liu, J. M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10270 · Cited by 27
Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors
Moriel‐Carretero, M., Ovejero, S., Gérus, M., Vryzas, D., & Constantinou, A. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201702136 · Cited by 26
A new look at molecular biology of breast cancer
Ma, C., Nepal, M. K., Kim, J., Fan, P., & Fei, P. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1507259 · Cited by 26
Regulation of cellular responses by deubiquitinating enzymes: an update
James, F. B. (2011) · Frontiers in bioscience · doi:10.2741/3980 · Cited by 26
Metadata
- Authors
- Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D.
- Affiliations
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- Hospital for Sick Children (CA)
- Oregon Health & Science University (US)
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 7
- Issue
- 2
- Pages
- 249-262
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1991841649
- Cited by
- 1,198
- References
- 71
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 14 · 2023: 20 · 2022: 15 · 2021: 24 · 2020: 25 · 2019: 41 · 2018: 28 · 2017: 20 · 2016: 54 · 2015: 49 · 2014: 51 · 2013: 44 · 2012: 66
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL54785-04, R01HL52725-04, R01HL052725)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK043889, R01DK43889-09)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, BRCA1, FANCD2 monoubiquitination, FANCA, FANCC, FANCF, FANCG, DNA repair, radiosensitivity, mitomycin C sensitivity, synaptonemal complex, meiotic chromosomes, nuclear foci, cancer susceptibility
- MeSH terms
- Animals, Cell Line, Cell Survival, DNA Damage, DNA-Binding Proteins, Fanconi Anemia, Fluorescent Antibody Technique, Genetic Complementation Test, Humans, Male, Meiosis, Nuclear Proteins, Protein Binding, Proteins, Radiation, Ionizing, Spermatocytes, Synaptonemal Complex, Ubiquitins, Ultraviolet Rays, Mitomycin, Cell Cycle Proteins, BRCA1 Protein, Active Transport, Cell Nucleus, Macromolecular Substances, Mice, Fanconi Anemia Complementation Group Proteins, Fanconi Anemia Complementation Group C Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review